Heartflow HTFL
NASDAQ HTFL
$49.75 -0.08 (-0.16%)
At close: Sep 30, 2026 · 4:00 PM EDT

Heartflow (HTFL) EBITDA Margin (2024 - 2025)

Updated

Heartflow (HTFL) posted EBITDA Margin of -33.34% for Q4 2025, up 8.02 percentage points from -41.36% a year earlier but down 3.52 percentage points from the prior quarter.

Analysis

Heartflow (HTFL) EBITDA Margin (2024 - 2025) Analysis & Trends

For FY2025, Heartflow's EBITDA Margin came in at -33.30%, up 11.10 percentage points from FY2024.

  • In prior years, Heartflow's EBITDA Margin was -44.40% in FY2024 (+33.80 pp) and -78.20% in FY2023.
  • Quarterly EBITDA Margin has run from a low of -41.36% in Q4 2024 to a high of -29.81% in Q3 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 24.20%
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 21.86%
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 28.51%
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 41.08%
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 25.55%
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 29.67%
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 28.17%
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 31.93%
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 24.62%
10 Heartflow 4.31 Bn 4.07 Bn 53.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -33.34%
Sep 30, 2025 -29.81%
Dec 31, 2024 -41.36%
Sep 30, 2024 -41.11%
API Access

Heartflow EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=HTFL&period=max&api_key=YOUR_API_KEY